The trademark application BEYOND STATINS was filed by Esperion Therapeutics, Inc., a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 24, 2020.
The Refusal with reference B 018316306 was Rejected according to Article 7(1)(b) EUTMR with decision issued on January 6, 2021 by the EUIPO.